Correlation between glucose-to-lymphocyte ratio and all-cause mortality in patients with pneumonia
- 1Department of Respiratory Medicine, Shaoxing Second Hospital
- 2Zhejiang Chinese Medical University
- 3Department of Respiratory and Critical Care Medicine, Cangnan Hospital of Wenzhou Medical University
Abstract
This study aims to evaluate the correlation between the glucose-to-lymphocyte ratio (GLR) and prognosis in patients with pneumonia admitted to the intensive care unit (ICU). This retrospective cohort study analyzed data from the MIMIC-IV database. A total of 4,049 ICU patients with pneumonia were included. GLR was calculated as log₂{[glucose (mg/dL) ÷ 18] ÷ [lymphocyte (×10⁹/L)]}. The optimal cut-off value (3.152) was determined using the Youden index. Cox proportional hazards regression, Kaplan-Meier survival curves, and restricted cubic splines were used to assess the association between GLR and mortality. The incremental predictive value of GLR was evaluated by receiver operating characteristic (ROC) curve analysis. Patients were stratified into low GLR (< 3.152, n = 2,091) and high GLR (≥ 3.152, n = 1,958) groups. High GLR was associated with significantly worse clinical outcomes. In the fully adjusted model, each one-unit increase in GLR was associated with a 5% increase in 30-day mortality risk (HR = 1.05, 95% CI: 1.01–1.10) and a 6% increase in 360-day mortality risk (HR = 1.06, 95% CI: 1.02–1.09). Using the binary classification, high GLR was associated with a 20% increase in 30-day mortality (HR = 1.20, 95% CI: 1.06–1.36) and a 21% increase in 360-day mortality (HR = 1.21, 95% CI: 1.10–1.33). RCS analysis revealed linear relationships for both endpoints (p for nonlinear > 0.05). Subgroup analyses revealed no statistically significant interaction across the prespecified subgroups (all p-values for interaction > 0.05). ROC analysis showed that adding GLR to SOFA improved the AUC from 0.625 to 0.719 for 30-day mortality and from 0.616 to 0.718 for 360-day mortality. GLR is associated with 30-day and 360-day mortality in ICU patients with pneumonia. As a low-cost, readily available biomarker, GLR may aid in early risk stratification and clinical decision-making.
Related
- Neutrophil-to-lymphocyte ratio is associated with in-hospital mortality in patients with cirrhosis and pneumonia: a multicenter retrospective study
- Association of the glucose-to-lymphocyte ratio with short-term mortality in critically ill patients with documented mitral valve disease: A retrospective cohort study
- Association between glucose-to-lymphocyte ratio and risk of in-hospital mortality in patients with acute ischemic stroke: a retrospective cohort study based on the MIMIC-IV database.
- Admission blood glucose and neutrophil-to-lymphocyte ratio provide independent and complementary prognostic value for in-hospital mortality in acute type A aortic dissection
- Predictive value of combined estimated plasma volume status and neutrophil-to-lymphocyte ratio for cardiovascular mortality in patients with acute myocardial infarction with heart failure
BibTeX
@article{wang2026correlation,
title = {{Correlation between glucose-to-lymphocyte ratio and all-cause mortality in patients with pneumonia}},
author = {Shidong Wang and Mengyuan Shen and Hongyan Han and Yuelin Cai and Keji Miao and Liang Wu},
journal = {Scientific Reports},
year = {2026},
month = aug,
doi = {10.1038/s41598-026-65985-5},
url = {https://doi.org/10.1038/s41598-026-65985-5},
note = {CC BY},
}
RIS
TY - JOUR
TI - Correlation between glucose-to-lymphocyte ratio and all-cause mortality in patients with pneumonia
AU - Shidong Wang
AU - Mengyuan Shen
AU - Hongyan Han
AU - Yuelin Cai
AU - Keji Miao
AU - Liang Wu
PY - 2026
DA - 2026/08/01
JO - Scientific Reports
DO - 10.1038/s41598-026-65985-5
UR - https://doi.org/10.1038/s41598-026-65985-5
AB - This study aims to evaluate the correlation between the glucose-to-lymphocyte ratio (GLR) and prognosis in patients with pneumonia admitted to the intensive care unit (ICU). This retrospective cohort study analyzed data from the MIMIC-IV database. A total of 4,049 ICU patients with pneumonia were included. GLR was calculated as log₂{[glucose (mg/dL) ÷ 18] ÷ [lymphocyte (×10⁹/L)]}. The optimal cut-off value (3.152) was determined using the Youden index. Cox proportional hazards regression, Kaplan-Meier survival curves, and restricted cubic splines were used to assess the association between GLR and mortality. The incremental predictive value of GLR was evaluated by receiver operating characteristic (ROC) curve analysis. Patients were stratified into low GLR (< 3.152, n = 2,091) and high GLR (≥ 3.152, n = 1,958) groups. High GLR was associated with significantly worse clinical outcomes. In the fully adjusted model, each one-unit increase in GLR was associated with a 5% increase in 30-day mortality risk (HR = 1.05, 95% CI: 1.01–1.10) and a 6% increase in 360-day mortality risk (HR = 1.06, 95% CI: 1.02–1.09). Using the binary classification, high GLR was associated with a 20% increase in 30-day mortality (HR = 1.20, 95% CI: 1.06–1.36) and a 21% increase in 360-day mortality (HR = 1.21, 95% CI: 1.10–1.33). RCS analysis revealed linear relationships for both endpoints (p for nonlinear > 0.05). Subgroup analyses revealed no statistically significant interaction across the prespecified subgroups (all p-values for interaction > 0.05). ROC analysis showed that adding GLR to SOFA improved the AUC from 0.625 to 0.719 for 30-day mortality and from 0.616 to 0.718 for 360-day mortality. GLR is associated with 30-day and 360-day mortality in ICU patients with pneumonia. As a low-cost, readily available biomarker, GLR may aid in early risk stratification and clinical decision-making.
SN - 2045-2322
ER -